Umeå University's logo

umu.sePublications
System disruptions
There are recurring service disruptions on some of the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (10 of 22) Show all publications
Winberg, A., Simonyté Sjödin, K., Öhlund, M. & West, C. E. (2026). Loss of symbiotic gut bacteria in children at diagnosis of food protein–induced enterocolitis syndrome. Journal of Allergy and Clinical Immunology
Open this publication in new window or tab >>Loss of symbiotic gut bacteria in children at diagnosis of food protein–induced enterocolitis syndrome
2026 (English)In: Journal of Allergy and Clinical Immunology, ISSN 0091-6749, E-ISSN 1097-6825Article in journal (Refereed) In press
Abstract [en]

Background: Gut microbial composition has been proposed to influence disease onset in children with food protein–induced enterocolitis syndrome (FPIES).

Objective: We sought to investigate differences in gut microbiota profiles in children with newly diagnosed FPIES and healthy control subjects.

Methods: Fecal samples were collected at FPIES diagnosis from 56 children stratified into 3 age groups: mean (SD) age 4.6 (0.5) months, 6.5 (0.6) months, and 11.7 (7.8) months. Gut microbiota profiles were analyzed using 16S ribosomal RNA gene amplicon sequencing and compared between children with FPIES and 43 age-matched control subjects.

Results: Age was the strongest determinant of gut microbiota composition, followed by FPIES status. β-diversity differed significantly between children with FPIES and control subjects (P < .01), primarily driven by shifts in Bacteroidota, Proteobacteria, Actinobacteriota, and Verrucomicrobiota. Children with FPIES had lower Bifidobacterium and higher abundances of Bacteroides, Haemophilus, and Veillonella. FPIES food triggers were associated with reduced Verrucomicrobiota abundance.

Conclusions: Children with FPIES exhibit gut microbial dysbiosis characterized by reduced Bifidobacterium and Verrucomicrobiota abundance, suggesting potential links between early-life microbiota development and disease pathogenesis.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
Bifidobacterium, food allergy, FPIES, gut, microbiota
National Category
Respiratory Medicine and Allergy
Identifiers
urn:nbn:se:umu:diva-253434 (URN)10.1016/j.jaci.2026.02.043 (DOI)41825597 (PubMedID)2-s2.0-105034544902 (Scopus ID)
Funder
Swedish Asthma and Allergy AssociationUmeå UniversityRegion VästerbottenMagnus Bergvall FoundationStiftelsen Syskonen Svenssons Stiftelse för Medicinsk ForskningConsul Berghs FoundationThe Kempe Foundations
Available from: 2026-05-27 Created: 2026-05-27 Last updated: 2026-05-27
Schwartz, P. J., Winbo, A., Sala, L., Crotti, L., Musu, G., Dagradi, F., . . . Gnecchi, M. (2026). MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome. European Heart Journal, 47(36), 5189-5199
Open this publication in new window or tab >>MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome
Show others...
2026 (English)In: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 47, no 36, p. 5189-5199Article in journal (Refereed) Published
Abstract [en]

Background and Aims: Modifier genes may cause different clinical phenotypes in patients with long QT syndrome (LQTS) carrying the same pathogenic variant. Variants in the MTMR4 gene have been previously associated, via patient-specific cardiomyocytes derived from induced pluripotent stem cells, with variable arrhythmic risk in a family with the p.Y111C-LQT1 mutation. This study aimed to evaluate the broader clinical impact of MTMR4 variants in patients with LQT1 and LQT2.

Methods: A total of 1192 LQTS patients were analysed: 638 with LQT1, 432 with LQT2, and 122 Swedish carriers of the p.Y111C-LQT1 variant. The association between MTMR4 variants and clinical severity was assessed by comparing patients with severe symptoms (cardiac arrest or syncope on beta-blockers) vs asymptomatic or mildly symptomatic individuals. ECG parameters, including Tpeak-Tend and T-wave heterogeneity, were also evaluated.

Results: In the LQT1 cohort, there was a significant decreasing pattern for cardiac events across MTMR4 genotypes (AA:15.9%, Aa:11.6%, aa:6.3%), while an opposite trend was apparent in the LQT2 cohort (AA:16.5%, Aa:18.2%, aa:27.6%). No pattern was apparent in the Swedish cohort. In the combined LQT1 cohort, the aa genotype was found in 15% of 702 mild/asymptomatic vs 1.7% of 58 with severe symptoms (P = .002). Vice versa, in LQT2, aa was more frequent in severe cases (24.1% vs 11.9%, P = .014). QTc was not associated with MTMR4, but the repolarization markers supported a gene-specific directionality of arrhythmic risk.

Conclusions: The MTMR4 minor allele in homozygosis exerts a gene-specific and opposite impact on arrhythmic risk in LQTS. This finding should influence risk stratification in clinical practice.

Place, publisher, year, edition, pages
Oxford University Press, 2026
Keywords
Long QT syndrome, Arrhythmias, Sudden cardiac death, Induced pluripotent stem cell-derived cardiomyocytes, NEDD4L, MTMR4
National Category
Cardiology and Cardiovascular Disease Medical Genetics and Genomics
Identifiers
urn:nbn:se:umu:diva-259586 (URN)10.1093/eurheartj/ehag294 (DOI)001763828500001 ()42128250 (PubMedID)2-s2.0-105051194513 (Scopus ID)
Available from: 2026-10-07 Created: 2026-10-07 Last updated: 2026-10-07Bibliographically approved
Simonyte, K., Sjödin, A., Rydén, P., Mogren, I., Domellöf, M., Lif Holgerson, P. & West, C. E. (2025). Early-life gut and oral microbiota development: a multi-niche study including mother-partner-infant triads. BMC Microbiology, 25(1), Article ID 751.
Open this publication in new window or tab >>Early-life gut and oral microbiota development: a multi-niche study including mother-partner-infant triads
Show others...
2025 (English)In: BMC Microbiology, E-ISSN 1471-2180, Vol. 25, no 1, article id 751Article in journal (Refereed) Published
Abstract [en]

Background: Early gastrointestinal microbiota establishment is crucial for host metabolism and immune development, with delivery mode and breastfeeding playing key roles. Vaginal delivery promotes colonization by maternal vaginal and gut microbes, while Caesarean section delivery leads to exposures of environmental and skin-derived microbiota. Although maternal contributions have been studied, the role of paternal exposure in shaping infant microbiota remains underexplored. We hypothesized that both parents influence infant microbiota establishment and therefore investigated the contributions of maternal and paternal microbes, as well as delivery mode, on infant oral and fecal microbiota within 48 h of birth and at 1 month of age.

Methods: We analysed the gut and oral microbiota of 264 pregnant women, 261 partners, and 266 infants using 16S rRNA gene amplicon sequencing. α-diversity (Shannon Index) was compared using Wilcoxon tests, and β-diversity (Bray–Curtis dissimilarity) was assessed with PERMANOVA and PERMDISP. Principal component analysis (PCA) based on centered log-ratio (CLR)-transformed genus-level data was used for ordination and visualisation of taxonomic structure. Differentially abundant taxa across niches and delivery modes were identified using Kruskal–Wallis and Wilcoxon tests with false discovery rate (FDR) correction, followed by linear discriminant analysis (LDA). Putative amplicon sequence variant (ASV) sharing between infants and family members was explored using tree-based phylogenetic plots showing taxon presence and relative abundance across sample types. All analyses were performed in R using established packages.

Results: Adults showed significantly higher microbial α-diversity than infants in both gut and oral samples. β-diversity analyses revealed distinct microbial community structures influenced by ecological niches and delivery mode. Within the first 48 h after birth, differential abundance analyses identified Lactobacillus crispatus in meconium and Blautia_A in oral swabs enriched in vaginally delivered infants. L. crispatus also emerged as a key marker of the vaginal microbiota in our cohort-wide comparison, while Blautia, typically a gut-associated genus, was also detected in parental rectal and meconium samples. This co-occurrence may reflect transient microbial seeding during vaginal delivery. However, due to the limited resolution of 16S rRNA gene sequencing, these patterns suggest ecological overlap rather than definitive evidence of vertical transmission.

Conclusions: Our findings demonstrate that delivery mode influences early gut and oral microbiota composition, with vaginal delivery associated with taxa also found in maternal samples. While we observed microbial continuity between infant and parental niches, we could not clearly distinguish partner-specific contributions—likely due to the limited resolution of 16S rRNA gene sequencing. These results highlight the importance of delivery-associated exposures in early microbial development and underscore the need for high-resolution approaches to better resolve microbial acquisition within families.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
Caesarean section, Gut microbiota, Infant, NorthPop, Oral microbiota, Vaginal delivery
National Category
Microbiology in the Medical Area Microbiology Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
urn:nbn:se:umu:diva-246771 (URN)10.1186/s12866-025-04521-3 (DOI)41241721 (PubMedID)2-s2.0-105021849293 (Scopus ID)
Funder
Swedish Research Council, 2018 - 02642Swedish Research Council, 2021 − 01637Swedish Research Council, 2023 − 01784Swedish Heart Lung Foundation, 2018 − 0641Ekhaga Foundation, 2018-40Region Västerbotten, RV 840681Swedish Society of Medicine, SLS 692 − 541
Available from: 2025-11-27 Created: 2025-11-27 Last updated: 2026-02-12Bibliographically approved
Sandås, K., Lewerentz, J., Karlsson, E., Karlsson, L., Sundell, D., Simonyté-Sjödin, K. & Sjodin, A. (2024). Nanometa Live: a user-friendly application for real-time metagenomic data analysis and pathogen identification. Bioinformatics, 40(3), Article ID btae108.
Open this publication in new window or tab >>Nanometa Live: a user-friendly application for real-time metagenomic data analysis and pathogen identification
Show others...
2024 (English)In: Bioinformatics, ISSN 1367-4803, E-ISSN 1367-4811, Vol. 40, no 3, article id btae108Article in journal (Refereed) Published
Abstract [en]

Summary: Nanometa Live presents a user-friendly interface designed for real-time metagenomic data analysis and pathogen identification utilizing Oxford Nanopore Technologies’ MinION and Flongle flow cells. It offers an efficient workflow and graphical interface for the visualization and interpretation of metagenomic data as it is being generated. Key features include automated BLAST validation, streamlined handling of custom Kraken2 databases, and a simplified graphical user interface for enhanced user experience. Nanometa Live is particularly notable for its capability to run without constant internet or server access once installed, setting it apart from similar tools. It provides a comprehensive view of taxonomic composition and facilitates the detection of user-defined pathogens or other species of interest, catering to both researchers and clinicians.

Availability and implementation: Nanometa Live has been implemented as a local web application using the Dash framework with Snakemake handling the data processing. The source code is freely accessible on the GitHub repository at https://github.com/FOIBioinformatics/nanometa_live and it is easily installable using Bioconda. It includes containerization support via Docker and Singularity, ensuring ease of use, reproducibility, and portability.

Place, publisher, year, edition, pages
Oxford University Press, 2024
National Category
Bioinformatics and Computational Biology Bioinformatics (Computational Biology)
Identifiers
urn:nbn:se:umu:diva-223056 (URN)10.1093/bioinformatics/btae108 (DOI)001177246700001 ()38407280 (PubMedID)2-s2.0-85187520952 (Scopus ID)
Funder
Swedish Armed Forces, A4001
Available from: 2024-04-22 Created: 2024-04-22 Last updated: 2025-02-05Bibliographically approved
Sjödin, K. S., Sjödin, A., Ruszczyński, M., Kristensen, M. B., Hernell, O., Szajewska, H. & West, C. E. (2023). Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial. BMC Biology, 21(1), Article ID 38.
Open this publication in new window or tab >>Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial
Show others...
2023 (English)In: BMC Biology, E-ISSN 1741-7007, Vol. 21, no 1, article id 38Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Formula-fed infants are at increased risk of infections. Due to the cross-talk between the mucosal systems of the gastrointestinal and respiratory tracts, adding synbiotics (prebiotics and probiotics) to infant formula may prevent infections even at distant sites. Infants that were born full term and weaned from breast milk were randomized to prebiotic formula (fructo- and galactooligosaccharides) or the same prebiotic formula with Lactobacillus paracasei ssp. paracasei F19 (synbiotics) from 1 to 6 months of age. The objective was to examine the synbiotic effects on gut microbiota development. RESULTS: Fecal samples collected at ages 1, 4, 6, and 12 months were analyzed using 16S rRNA gene sequencing and a combination of untargeted gas chromatography-mass spectrometry/liquid chromatography-mass spectrometry. These analyses revealed that the synbiotic group had a lower abundance of Klebsiella, a higher abundance of Bifidobacterium breve compared to the prebiotic group, and increases in the anti-microbial metabolite d-3-phenyllactic acid. We also analyzed the fecal metagenome and antibiotic resistome in the 11 infants that had been diagnosed with lower respiratory tract infection (cases) and 11 matched controls using deep metagenomic sequencing. Cases with lower respiratory tract infection had a higher abundance of Klebsiella species and antimicrobial resistance genes related to Klebsiella pneumoniae, compared to controls. The results obtained using 16S rRNA gene amplicon and metagenomic sequencing were confirmed in silico by successful recovery of the metagenome-assembled genomes of the bacteria of interest. CONCLUSIONS: This study demonstrates the additional benefit of feeding specific synbiotics to formula-fed infants over prebiotics only. Synbiotic feeding led to the underrepresentation of Klebsiella, enrichment of bifidobacteria, and increases in microbial degradation metabolites implicated in immune signaling and in the gut-lung and gut-skin axes. Our findings support future clinical evaluation of synbiotic formula in the prevention of infections and associated antibiotic treatment as a primary outcome when breastfeeding is not feasible. TRIAL REGISTRATION: ClinicalTrials.gov NCT01625273. Retrospectively registered on 21 June 2012.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2023
Keywords
Antibiotics, Bifidobacteria, Infant gut microbiota, Klebsiella, Lower respiratory tract infection, Prebiotics, Probiotics
National Category
Nutrition and Dietetics Pediatrics
Identifiers
urn:nbn:se:umu:diva-205355 (URN)10.1186/s12915-023-01531-3 (DOI)000936843800002 ()36803508 (PubMedID)2-s2.0-85148399778 (Scopus ID)
Funder
Umeå UniversityRegion VästerbottenMagnus Bergvall FoundationKnut and Alice Wallenberg FoundationSwedish Research Council
Available from: 2023-04-03 Created: 2023-04-03 Last updated: 2025-10-21Bibliographically approved
Bzioueche, H., Sjödin, K. S., West, C. E., Khemis, A., Rocchi, S., Passeron, T. & Tulic, M. K. (2021). Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis: Link with Mitochondrial and Immune Changes. Journal of Investigative Dermatology, 141(9), 2280-2290
Open this publication in new window or tab >>Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis: Link with Mitochondrial and Immune Changes
Show others...
2021 (English)In: Journal of Investigative Dermatology, ISSN 0022-202X, E-ISSN 1523-1747, Vol. 141, no 9, p. 2280-2290Article in journal (Refereed) Published
Abstract [en]

Vitiligo is an autoimmune disease characterized by patchy, white skin owing to melanocyte loss. Commensal cutaneous or gut dysbiosis has been linked to various dermatological disorders. In this study, we studied the skin and gut microbiota of patients with vitiligo compared with those of healthy controls. We obtained swabs and biopsies from both lesional and nonlesional skin as well as stool and blood samples from each individual. We detected reduced richness and diversity of microbiota in the stools of subjects with vitiligo compared with the stools of the controls (P < 0.01). Skin swabs had greater α-diversity than biopsies (P < 0.001); swabs from lesional sites were primarily depleted of Staphylococcus compared with those from nonlesional sites (P < 0.02). Sampling deeper layers from the same patients showed differences in both α- and β-diversity between samples with decreased richness and distribution of species (P < 0.01) in the lesional site. Biopsy microbiota from the lesional skin had distinct microbiota composition, which was depleted of protective Bifidobacterium and Bacteroides but was enriched in Proteobacteria, Streptococcus, Mycoplasma, and mtDNA (P < 0.001); the latter increased in the same patients with heightened innate immunity and stress markers in their blood (P < 0.05). These data describe vitiligo-specific cutaneous and gut microbiota and a link between skin dysbiosis, mitochondrial damage, and immunity in patients with vitiligo.

Place, publisher, year, edition, pages
Elsevier, 2021
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:umu:diva-189892 (URN)10.1016/j.jid.2021.01.036 (DOI)000689355100138 ()33771527 (PubMedID)2-s2.0-85104986767 (Scopus ID)
Available from: 2021-11-24 Created: 2021-11-24 Last updated: 2025-02-11Bibliographically approved
Sjödin, K. S., Domellöf, M., Lagerqvist, C., Hernell, O., Lönnerdal, B., Szymlek-Gay, E. A., . . . Lind, T. (2019). Administration of ferrous sulfate drops has significant effects on the gut microbiota of iron-sufficient infants: a randomised controlled study [Letter to the editor]. Gut, 68(11)
Open this publication in new window or tab >>Administration of ferrous sulfate drops has significant effects on the gut microbiota of iron-sufficient infants: a randomised controlled study
Show others...
2019 (English)In: Gut, ISSN 0017-5749, E-ISSN 1468-3288, Vol. 68, no 11Article in journal, Letter (Refereed) Published
Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2019
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:umu:diva-167039 (URN)10.1136/gutjnl-2018-316988 (DOI)000497817400023 ()30343273 (PubMedID)2-s2.0-85055356819 (Scopus ID)
Funder
Västerbotten County Council
Available from: 2020-01-09 Created: 2020-01-09 Last updated: 2025-10-21Bibliographically approved
Simonyté Sjödin, K., Hammarström, M.-L., Rydén, P., Sjödin, A., Hernell, O., Engstrand, L. & West, C. E. (2019). Temporal and long-term gut microbiota variation in allergic disease: a prospective study from infancy to school age. Allergy. European Journal of Allergy and Clinical Immunology, 74(1), 176-185
Open this publication in new window or tab >>Temporal and long-term gut microbiota variation in allergic disease: a prospective study from infancy to school age
Show others...
2019 (English)In: Allergy. European Journal of Allergy and Clinical Immunology, ISSN 0105-4538, E-ISSN 1398-9995, Vol. 74, no 1, p. 176-185Article in journal (Refereed) Published
Abstract [en]

Background: Compositional changes in the early‐life gut microbiota have been implicated in IgE‐associated allergic diseases, but there is lack of longitudinal studies. We examined gut microbiota development from infancy to school age in relation to onset of IgE‐associated allergic diseases. At 8 years of age, we also examined the relationship between gut microbiota and T‐cell regulation, estimated as responses to polyclonal T‐cell activation.

Methods: Stool samples were collected from 93 children at 4, 6, 13 months, and 8 years of age. The gut microbiota was profiled using 16S rRNA gene sequencing. Peripheral blood was drawn from all children, and mononuclear cells were polyclonally activated. Levels of IL‐10 and FOXP3 mRNA copies were determined using real‐time quantitative reverse transcriptase‐PCR.

Results: At 8 years of age, 21 children were diagnosed with IgE‐associated allergic disease and 90% displayed allergic comorbidity. Seventy‐two children were nonallergic and nonsensitized. Statistical tests with multiple testing corrections demonstrated temporal underrepresentation of Ruminococcus and consistent underrepresentation of Bacteroides, Prevotella, and Coprococcus in allergic compared to nonallergic children from infancy to school age. The gut microbiota of the allergic 8‐year‐olds was enriched in Bifidobacteriumand depleted of Lactobacillus, Enterococcus, and Lachnospira. In allergic 8‐year-olds, Faecalibacterium correlated with IL‐10 mRNA levels (rs = 0.49, Padj = 0.02) with the same trend for FOXP3 (rs = 0.39, Padj = 0.08).

Conclusions: We identified both temporal and long‐term variation in the differential abundance of specific bacterial genera in children developing IgE‐associated allergic disease. Improved dietary interventions aiming at expanding immune‐modulatory taxa could be studied for prevention of allergic disease.

Place, publisher, year, edition, pages
John Wiley & Sons, 2019
Keywords
allergy, diversity, intestinal colonization, microbiome, T-cell response
National Category
Immunology in the medical area
Identifiers
urn:nbn:se:umu:diva-157612 (URN)10.1111/all.13485 (DOI)000459664100017 ()29786876 (PubMedID)2-s2.0-85055285542 (Scopus ID)
Available from: 2019-03-27 Created: 2019-03-27 Last updated: 2025-10-21Bibliographically approved
Sjödin, K. S., Vidman, L., Rydén, P. & West, C. E. (2016). Emerging evidence of the role of gut microbiota in the development of allergic diseases. Current Opinion in Allergy and Clinical Immunology, 16(4), 390-395
Open this publication in new window or tab >>Emerging evidence of the role of gut microbiota in the development of allergic diseases
2016 (English)In: Current Opinion in Allergy and Clinical Immunology, ISSN 1528-4050, E-ISSN 1473-6322, Vol. 16, no 4, p. 390-395Article, review/survey (Refereed) Published
Abstract [en]

Purpose of review The purpose is to review recent studies examining the role of gut microbiota in allergic diseases and asthma.

Recent findings Work in experimental models gives further evidence that a disturbed gut microbiota influences the propensity to develop allergic manifestations, and that changing the gut microbiota by dietary means (high fiber/acetate or prebiotics) in pregnancy may reduce the risk of allergic airways disease and food allergy in the offspring, respectively. The gut microbiome in established allergic disease and prior to disease onset has also been assessed in clinical trials. One study demonstrated a strong association between high abundance of Faecalibacterium prausnitzii and decreased levels of butyrate and propionate, and established eczema. Lower relative abundance of Ruminococcaceae appears to be implicated in food sensitization and to precede the development of atopic eczema. Decreased relative abundance of Lachnospira, Veillonella, Faecalibacterium, and Rothia in early infancy was reported to be associated with increased asthma risk. Inoculation of germ-free mice with these genera decreased airway inflammation in their offspring thereby proposing a causal role of bacteria in preventing allergic airways disease.

Summary Gut microbiome research is an actively developing field. Although candidate bacterial taxa have been reported it still remains unclear which bacteria (or other microbes), in which numbers and combinations, and when during the gut colonization process may prevent allergic diseases and asthma. There is still a call for standardized approaches that will enable direct comparison of different studies.

Keywords
allergic disease, asthma, biodiversity, gut microbiome, homeostasis, immunity
National Category
Immunology in the medical area Respiratory Medicine and Allergy
Identifiers
urn:nbn:se:umu:diva-124315 (URN)10.1097/ACI.0000000000000277 (DOI)000379587800015 ()2-s2.0-84973163312 (Scopus ID)
External cooperation:
Available from: 2016-09-06 Created: 2016-08-04 Last updated: 2024-07-02Bibliographically approved
Stomby, A., Simonyte, K., Mellberg, C., Ryberg, M., Stimson, R. H., Larsson, C., . . . Olsson, T. (2015). Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women. International Journal of Obesity, 39(5), 814-819
Open this publication in new window or tab >>Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women
Show others...
2015 (English)In: International Journal of Obesity, ISSN 0307-0565, E-ISSN 1476-5497, Vol. 39, no 5, p. 814-819Article in journal (Refereed) Published
Abstract [en]

Background/Objectives: Tissue-specific glucocorticoid metabolism is altered in obesity, and may increase cardiovascular risk. This dysregulation is normalized by short-term calorie restriction and weight loss, an effect that varies with dietary macronutrient composition. However, tissue-specific glucocorticoid metabolism has not been studied during long-term (>6 months) dietary interventions. Therefore our aim was to test whether long-term dietary interventions, either a paleolithic-type diet (PD) or a diet according to Nordic nutrition recommendations (NNR) could normalize tissue-specific glucocorticoid metabolism in overweight and obese women.

Subjects/Methods: Forty-nine overweight/obese postmenopausal women were randomized to a paleolithic diet or a diet according to NNR for 24 months. At baseline, 6 and 24 months anthropometric measurements, insulin sensitivity, excretion of urinary glucocorticoid metabolites in 24-hour collections, conversion of orally administered cortisone to plasma cortisol and transcript levels of 11β hydroxysteroid dehydrogenase type 1 (11βHSD1) in subcutaneous adipose tissue were studied.

Results: Both diet groups achieved significant and sustained weight loss. Weight loss with the PD was greater than on NNR diet after 6 months (P<0.001) but similar at 24 months. Urinary measurement of 5α-reductase activity was increased after 24 months in both groups compared with baseline (P<0.001). Subcutaneous adipose tissue 11βHSD1 gene expression decreased at 6 and 24 months in both diet groups (P=0.036). Consistent with increased liver 11βHSD1, conversion of oral cortisone to cortisol increased at 6 months (P=0.023) but was unchanged compared with baseline by 24 months.

Conclusions: Long-term weight loss in postmenopausal women has tissue-specific and time-dependent effects on glucocorticoid metabolism. This may alter local-tissue cortisol exposure contributing to improved metabolic function during weight loss.

National Category
Nutrition and Dietetics
Identifiers
urn:nbn:se:umu:diva-96782 (URN)10.1038/ijo.2014.188 (DOI)000354097900013 ()25349058 (PubMedID)2-s2.0-84928924061 (Scopus ID)
Available from: 2014-12-03 Created: 2014-12-03 Last updated: 2025-02-11Bibliographically approved
Projects
Nicotinamide N-methyltransferase (NNMT) in obesity and type 2 diabetes [2012-06616_VR]; Umeå University
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-1323-9913

Search in DiVA

Show all publications